Speakers
Tahamtan Ahmadi, M.D., Ph.D.
EVP & Chief Medical Officer
Genmab
Farideh Bischoff, Ph.D.
Chief Medical Officer & Global Head of Diagnostics
Heranova Lifesciences Inc.
Melissa Bonner, Ph.D.
Chief Scientific Officer
nChroma Bio Inc.
Luciana Borio, M.D.
Venture Partner
ARCH Venture Partners
Marty Burke, M.D., Ph.D.
Professor of Chemical Innovation
University of Illinois Urbana–Champaign
Rachel Butler
President & Board Director
Catalytic Impact Foundation
Todd Carter, Ph.D.
Chief Scientific Officer
Voyager Therapeutics
Hearn Jay Cho, M.D., Ph.D.
Chief Medical Officer
Multiple Myeloma Research Foundation
Fred Chong, Ph.D.
Professor of Computer Science
University of Chicago
Alex Cogdill, Ph.D.
Head, Strategic Initiatives, Global Business Development
Daiichi Sankyo
Adam Cotton, Ph.D.
Associate
Novartis Venture Fund
Guillermo Del Angel, Ph.D.
Rare Disease and Data Science Head, Center for Genomics Research
AstraZeneca
Tracy Dooley, M.D.
Venture Partner
Institute for Follicular Lymphoma Innovation
Jakob Dupont, M.D.
Executive Partner
Sofinnova Investments
Aaron Esser-Kahn, Ph.D.
Professor of Molecular Engineering
University of Chicago
Stacy Feld
Global Head, External Scientific Innovation
Johnson & Johnson
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
Chris Garabedian
Portfolio Manager, PXV Fund and CEO,
Xontogeny
Chuan He, Ph.D.
Professor of Chemistry, Biochemistry, and Molecular Biology
University of Chicago
Sasha Huhalov
Head of Search and Evaluation
Takeda
Ross Jeggo, Ph.D.
Head of Neurodegeneration and Emerging Research
Biogen
Alyssa Johnsen, M.D., Ph.D.
SVP, Global Therapeutic Area Head for Immunology and Oncology Development
Sanofi
Gopal Karemore Ph.D.,
Global Quantum Lead in Healthcare and Life Sciences
IBM
Jamie Kasuboski, Ph.D.
Partner & Head of Research
Luma Group
Hilary Keeley
Executive Director
The Sontag Foundation
Shana Kelley
President
Chan Zuckerberg Biohub Chicago
Sean Khozin, M.D.
CEO
CEO Roundtable on cancer
Selina Koch, Ph.D.
Executive Editor, Head of Intelligence & Research
BioCentury Inc.
Gigi Kwik Gronvall, Ph.D.
Professor, Environmental Health and Engineering
Johns Hopkins Bloomberg School of Public Health
Shwetha Lakshmipathi, Ph.D.
Director
Institute for Follicular Lymphoma Innovation
John Lin, M.D., Ph.D.
SVP, Immuno-Oncology & Head of Bispecifics
Regeneron
Patrick Malone, M.D., PH.D.
Partner
KdT Ventures
Lauren Martz
Executive Director of Biopharma Intelligence
BioCentury Inc.
Frank Nestle, M.D.
Partner and Chief Executive Officer, 3DC
Deerfield Management
Stephanie Oestreich, Ph.D.
Managing Director
Myeloma Investment Fund
Deborah Palestrant, Ph.D.
Executive Chair, 4:59 Initiative and Partner,
5AM Ventures
Paul Peloso, M.D.
Chief Medical Officer
COUR Pharmaceuticals
Koustubh Ranade, Ph.D.
SVP and Head of Translational Medicine
Immunocore
Klaus Romero, M.D.
CEO
Critical Path Institute
Justin Ryder, Ph.D.
Professor
Northwestern University Feinberg School of Medicine
Tay Salimullah
Venture Partner
4BIO Capital
Kate Sasser, Ph.D.
Chief Scientific Officer
Tempus AI
Jon Sedgwick, Ph.D.
SVP & Global Head Discovery
AbbVie
Adam Sonabend, M.D.
Associate Professor of Neurosurgery, Director of Translational Neuro-oncology,
Northwestern University
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Misti Ushio, Ph.D.
Managing Partner
Digitalis Ventures
Jérôme Van Biervliet, Ph.D.
Managing Director
VIB
Ben Weintraub, Ph.D.
President
inThought Research
John Wojcik, M.D., Ph.D.
Executive Director, Head Translational Molecular Biomarkers
Merck
Peter Wright, Ph.D.
Partner
McKinsey & Company
Peter Wright, Ph.D.
Partner
McKinsey & Company
Shanshan Xu, M.D., Ph.D.
CEO
Bambusa Therapeutics
Guang Yang, Ph.D.
Partner
McKinsey & Company
Guang Yang, Ph.D.
Partner
McKinsey & Company
Travis Young, Ph.D.
VP, Biologics
CALIBR, Scripps Research
Shann Yu, Ph.D.
Associate Director
AbbVie Ventures
Maziar Zarrehparvar
Fund Advisor
Kurma Partners
Ashley Zehnder, Ph.D.
Founder & CEO
Fauna Bio